Renji Hospital is a general hospital in the Pudong District of Shanghai, China, with the rank of "Grade 3, Class A". The hospital is a university hospital affiliated to the Shanghai Jiao Tong University School of Medicine.

There are 1,600 beds in Renji Hospital.

During the past decade, Renji Hospital conducted 303 clinical trials. In the 10-year time frame, 303 clinical trials started and 19 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 157 clinical trials started and 15 clinical trials were completed. i.e. 9.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renji Hospital" #1 sponsor was "RenJi Hospital" with 173 trials, followed by "Shanghai Jiao Tong University School of Medicine" with 32 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Beijing Friendship Hospital" with 6 trials sponsored. Other sponsors include 153 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renji Hospital" #1 collaborator was "RenJi Hospital" with 20 trials as a collaborator, "Ruijin Hospital" with 12 trials as a collaborator, "Shanghai Zhongshan Hospital" with 12 trials as a collaborator, "Fudan University" with 8 trials as a collaborator and "Peking University First Hospital" with 8 trials as a collaborator. Other collaborators include 396 different institutions and companies that were collaborators in the rest 243 trials.

According to Clinical.Site data, the most researched conditions in "Renji Hospital" are "Helicobacter Pylori Infection" (13 trials), "Gastric Cancer" (11 trials), "Pulmonary Arterial Hypertension" (7 trials), "Breast Cancer" (6 trials) and "Knee Osteoarthritis" (6 trials). Many other conditions were trialed in "Renji Hospital" in a lesser frequency.

Most popular intervention types in "Renji Hospital" are "Drug" (205 trials), "Device" (44 trials), "Procedure" (43 trials), "Other" (34 trials) and "Diagnostic Test" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Esomeprazole" (12 trials), "Amoxicillin" (11 trials), "Bismuth Potassium Citrate" (11 trials) and "Cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Renji Hospital" are 347 trials for "All" genders, 28 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 123 active trials in "Renji Hospital". 15 are not yet recruiting, 88 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 134 completed trials in Renji Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Renji Hospital, 16 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 57 trials, and there were also 99 trials that are defined as “Not Applicable".